PolarityTE rises on new Chinese patent for skin treatment technology

RegenETP,

12/07/2021 13:50

** Tissue-based treatment developer's shares  PTE.O  rise
~6% to $0.93 premarket
    ** Co receives Chinese patent for skin-regenerative
treatments utilizing its technology (https://refini.tv/3k7ufWm)
    ** As per China's new law, total patent term from the
approval date of the new drug shall not exceed 14 years
    ** Stock up 28.9% this year, as of last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))